Edition:
United States

Ocera Therapeutics Inc (OCRX.OQ)

OCRX.OQ on NASDAQ Stock Exchange Global Market

2.60USD
4:00pm EDT
Change (% chg)

$-0.05 (-1.89%)
Prev Close
$2.65
Open
$2.59
Day's High
$2.60
Day's Low
$2.59
Volume
7,264
Avg. Vol
10,928
52-wk High
$4.55
52-wk Low
$1.77

OCRX.OQ

Chart for OCRX.OQ

About

Ocera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on acute and chronic orphan liver diseases. The Company is focused on the development and commercialization of its clinical candidate, OCR-002, for the treatment of hepatic encephalopathy (HE). OCR-002 is a molecule, ornithine... (more)

Overall

Beta: 2.31
Market Cap(Mil.): $56.46
Shares Outstanding(Mil.): 21.31
Dividend: --
Yield (%): --

Financials

  OCRX.OQ Industry Sector
P/E (TTM): -- 39.19 39.69
EPS (TTM): -1.33 -- --
ROI: -68.48 15.23 14.44
ROE: -77.57 16.16 15.49

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.